首页>The Pediatric infectious disease journal>Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine Randomized Phase IIIb Trial in Healthy Participants 9-60 Years of Age in the Philippines
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine Randomized Phase IIIb Trial in Healthy Participants 9-60 Years of Age in the Philippines
作者单位:Res Inst Trop Med, Alabang Muntinlupa City, Philippines[1]Sanofi Pasteur, Av Univ 1738, Mexico City 04000, DF, Mexico[2]Sanofi Pasteur, Lyon, France[3]Philippine Childrens Med Ctr, Quezon City, Philippines[4]Far Eastern Univ, Nicanor Reyes Med Fdn, Quezon City, Philippines[5]